Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank82
3Y CAGR+69.0%
5Y CAGR-10.5%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+69.0%/yr
Annual compound
5Y CAGR
-10.5%/yr
Recent acceleration
Percentile
P82
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.25M | +1181.3% |
| 2024 | $566000.00 | +44.4% |
| 2023 | $392000.00 | -73.9% |
| 2022 | $1.50M | -99.3% |
| 2021 | $208.38M | +1551.6% |
| 2020 | $12.62M | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |